Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2019-06-03 Regulatory Filings
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
INTRASENSE : Myrian® XP-Mammo reçoit son marquage CE
Regulatory Filings Classification · 100% confidence The document is a 'Communiqué de presse' (Press Release) dated June 3, 2019, announcing that the company Intrasense has received CE marking for its new medical imaging software application, Myrian®XP-Mammo. This is an announcement regarding a product development milestone and market entry, not a formal financial report (like 10-K, IR, ER) or a shareholder communication (like DEF 14A, AGM-R). It is a general corporate announcement that does not fit the specific categories like M&A (TAR), Director's Dealing (DIRS), or Capital Change (CAP). Given the options, the most appropriate general category for a significant, non-financial regulatory/product update that doesn't fit elsewhere is 'Regulatory Filings' (RNS), as CE marking is a form of regulatory approval for market access in Europe. However, since it is a press release announcing a business development (product launch readiness), and not a mandatory regulatory filing in the SEC sense, it is best classified as a general corporate announcement. Since 'RNS' is defined as 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories,' it serves as the best fit for this type of press release announcing a key operational/regulatory milestone.
2019-06-03 French
INTRASENSE : Myrian® XP-Mammo has been CE marked
Regulatory Filings Classification · 100% confidence The document is a press release dated June 3rd, 2019, announcing that the company Intrasense obtained CE marking for its Myrian® XP-Mammo application. It details the product, its features, and future delivery plans. This type of announcement, which is a general corporate update regarding product certification and business development, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or mandatory regulatory filings (like DIRS, DIV, DEF 14A). Since it is a general corporate announcement that doesn't fit other specific categories, the most appropriate fallback classification is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory or significant corporate announcements not covered elsewhere.
2019-06-03 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 98% confidence The document is explicitly titled "Informations sur l'Assemblée Générale des actionnaires du 5 juin 2019" (Information on the Shareholders' General Meeting of June 5, 2019). It discusses the submission of additional resolutions by shareholders, the Board's recommendation against them, the handling of written questions, and the proposed ratification of a new director's co-optation to be voted upon at the upcoming General Meeting. These elements strongly indicate that the document is related to the preparation, agenda, or materials for an Annual General Meeting (AGM). While it contains some management commentary on 2018 results, the primary focus and context are the shareholder meeting proceedings. Therefore, the most appropriate classification is AGM Information (AGM-R).
2019-05-15 French
RAPPORT FINANCIER ANNUEL DU CONSEIL D’ADMINISTRATION SUR LES COMPTES DE L’EXERCICE CLOS LE 31 DÉCEMBRE 2018 (INCLUANT LE RAPPORT DE GESTION)
Management Reports Classification · 99% confidence The document is titled "RAPPORT FINANCIER ANNUEL DU CONSEIL D'ADMINISTRATION SUR LES COMPTES DE L'EXERCICE CLOS LE 31 DECEMBRE 2018 (INCLUANT LE RAPPORT DE GESTION)" (Annual Financial Report of the Board of Directors on the Accounts for the Year Ended December 31, 2018 (Including the Management Report)). This explicitly identifies it as a comprehensive annual financial report covering the full fiscal year (December 31, 2018). Although it is in French, the content structure (Management Report, financial review, governance changes, financing details) aligns perfectly with the scope of a 10-K (Annual Report), which is the standard classification for such comprehensive yearly filings, regardless of the specific local regulatory code (like the French 'Document d'Enregistrement Universel' or 'Rapport Annuel'). The document length is substantial (412,299 chars), confirming it is the full report, not just an announcement (RPA/RNS).
2019-05-08 French
Intrasense™ and Radboudumc sign a multiyear partnership, deploying Myrian® XP-Prostate application as a worldwide reference
Regulatory Filings Classification · 100% confidence The document is a press release dated April 29, 2019, announcing a multiyear partnership between Intrasense and Radboudumc regarding the deployment of the Myrian® XP-Prostate application. This type of announcement, detailing a significant business agreement, partnership, or commercial success, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or mandatory regulatory filings (like DIRS, DIV, DEF 14A). It is a general corporate announcement regarding business operations and strategy. Since it is not a standard financial report, an earnings release, or a specific regulatory filing like a director's dealing or dividend notice, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous corporate announcements that are released publicly.
2019-04-29 English
Intrasense™ et Radboudumc signent un partenariat pluriannuel pour le déploiement de Myrian® XP Prostate
Regulatory Filings Classification · 95% confidence The document is a 'Communiqué de presse' (Press Release) dated April 29, 2019, announcing a multi-year partnership between Intrasense and Radboudumc for the deployment of Myrian® XP Prostate software. This is a commercial announcement detailing a business agreement and its implications for the company's revenue and market position. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since it is a press release announcing a significant business development, it fits best under the general category for regulatory announcements or significant corporate news that doesn't fit a more specific code. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate press release announcing a partnership, although 'Report Publication Announcement' (RPA) is sometimes used for announcements, this document is the news itself, not an announcement *about* another report's publication. Therefore, RNS is the best fit as a general corporate announcement.
2019-04-29 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.